Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.
作者信息
Groot Koerkamp B, Wiggers J K, Gonen M, Doussot A, Allen P J, Besselink M G H, Blumgart L H, Busch O R C, D'Angelica M I, DeMatteo R P, Gouma D J, Kingham T P, van Gulik T M, Jarnagin W R
出版信息
Ann Oncol. 2016 Apr;27(4):753. doi: 10.1093/annonc/mdw063. Epub 2016 Feb 25.
Abstract
摘要
相似文献
1
Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.肝门周围胆管癌切除术后的生存情况——一种预后列线图的开发与外部验证
Ann Oncol. 2016 Apr;27(4):753. doi: 10.1093/annonc/mdw063. Epub 2016 Feb 25.
2
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.可切除性肝门部胆管癌患者预后列线图的建立与验证
Oncotarget. 2016 Jun 14;7(24):37319-37330. doi: 10.18632/oncotarget.9104.
3
A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.一种新的预后评分系统，利用术前可得因素预测肝门周围胆管癌手术切除后的生存情况。
Surgery. 2016 Mar;159(3):842-51. doi: 10.1016/j.surg.2015.10.027. Epub 2015 Dec 10.
4
Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.肝门部胆管癌患者行肝胆切除术后基于炎症的预后评分评估
J Gastroenterol. 2016 Feb;51(2):153-61. doi: 10.1007/s00535-015-1103-y. Epub 2015 Jul 18.
5
Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.肝门周围胆管癌的外科治疗：孔敬府的经验
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4. doi: 10.1002/jhbp.74. Epub 2014 Jan 27.
6
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.列线图预测肝内胆管细胞癌切除术后的长期生存：东西方经验。
JAMA Surg. 2014 May;149(5):432-8. doi: 10.1001/jamasurg.2013.5168.
7
A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma.肝内胆管癌肝切除术后患者总生存的预后列线图
Anticancer Res. 2016 Aug;36(8):4249-58.
8
Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach.根治性切除后肝门周围胆管癌的复发：采用密切术后随访方法的大型队列分析。
Surgery. 2018 Apr;163(4):732-738. doi: 10.1016/j.surg.2017.08.011. Epub 2018 Jan 11.
9
[Expert recommendation for operational norms of laparoscopic radical resection of perihilar cholangiocarcinoma].[肝门部胆管癌腹腔镜根治性切除术操作规范专家推荐意见]
Zhonghua Wai Ke Za Zhi. 2019 Aug 1;57(8):561-567. doi: 10.3760/cma.j.issn.0529-5815.2019.08.001.
10
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.基于生存风险分层的肝内胆管癌肝切除术后辅助经动脉化疗栓塞术
Oncologist. 2015 Jun;20(6):640-7. doi: 10.1634/theoncologist.2014-0470. Epub 2015 May 8.
引用本文的文献
1
Predicting survival rates: the power of prognostic nomograms in distal cholangiocarcinoma.预测生存率：预后列线图在远端胆管癌中的作用
Front Oncol. 2025 Jan 27;15:1478836. doi: 10.3389/fonc.2025.1478836. eCollection 2025.
2
Total laparoscopic radical resection of hilar cholangiocarcinoma: preliminary experience of a single center.腹腔镜肝门部胆管癌根治术：单中心初步经验。
BMC Surg. 2024 Aug 24;24(1):241. doi: 10.1186/s12893-024-02533-w.
3
Multimodal prehabilitation program in patients with resectable perihilar cholangiocarcinoma: keypoints for an implementation protocol and literature review.可切除的肝门周围胆管癌患者的多模态预康复计划：实施方案的关键点和文献复习。
Langenbecks Arch Surg. 2024 Feb 14;409(1):61. doi: 10.1007/s00423-024-03251-w.
4
KLF4 suppresses the proliferation of perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT.KLF4 通过负向调控 GDF15 和磷酸化 AKT 抑制肝门部胆管癌的增殖。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8659. Epub 2023 Nov 8.
5
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.英国胃肠病学会胆管癌诊断和管理指南。
Gut. 2023 Dec 7;73(1):16-46. doi: 10.1136/gutjnl-2023-330029.
6
Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence.高复发风险的肝门部胆管癌患者术后辅助化疗免疫治疗的真实世界经验。
Cancer Immunol Immunother. 2023 Jun;72(6):1753-1761. doi: 10.1007/s00262-022-03362-7. Epub 2023 Jan 17.
7
Early postoperative decrease of skeletal muscle mass predicts recurrence and poor survival after surgical resection for perihilar cholangiocarcinoma.术后早期骨骼肌量减少预测肝门周围胆管癌切除术后复发和不良生存。
BMC Cancer. 2022 Dec 28;22(1):1358. doi: 10.1186/s12885-022-10453-2.
8
Characterization of the Estrogen Response Helps to Predict Prognosis and Identify Potential Therapeutic Targets in Cholangiocarcinoma.雌激素反应的特征有助于预测胆管癌的预后并确定潜在治疗靶点。
Front Oncol. 2022 May 19;12:870840. doi: 10.3389/fonc.2022.870840. eCollection 2022.
9
Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?胆管癌中的同源重组修复：PARP抑制的主要靶点？
Cancers (Basel). 2022 May 23;14(10):2561. doi: 10.3390/cancers14102561.
10
Adjuvant treatment in biliary tract cancer.胆管癌的辅助治疗。
Transl Cancer Res. 2019 Apr;8(Suppl 3):S289-S296. doi: 10.21037/tcr.2018.08.17.
Zotero 插件